Abstract |
We investigated the contributions of the structural proteins of severe acute respiratory syndrome (SARS) coronavirus (CoV) to protective immunity by expressing them individually and in combinations from a recombinant parainfluenza virus (PIV) type 3 vector called BHPIV3. This vector provided direct immunization of the respiratory tract, the major site of SARS transmission, replication, and disease. The BHPIV3/SARS recombinants were evaluated for immunogenicity and protective efficacy in hamsters, which support a high level of pulmonary SARS-CoV replication. A single intranasal administration of BHPIV3 expressing the SARS-CoV spike protein (S) induced a high titer of SARS-CoV-neutralizing serum antibodies, only 2-fold less than that induced by SARS-CoV infection. The expression of S with the two other putative virion envelope proteins, the matrix M and small envelope E proteins, did not augment the neutralizing antibody response. In absence of S, expression of M and E or the nucleocapsid protein N did not induce a detectable serum SARS-CoV- neutralizing antibody response. Immunization with BHPIV3 expressing S provided complete protection against SARS-CoV challenge in the lower respiratory tract and partial protection in the upper respiratory tract. This was augmented slightly by coexpression with M and E. Expression of M, E, or N in the absence of S did not confer detectable protection. These results identify S among the structural proteins as the only significant SARS-CoV neutralization antigen and protective antigen and show that a single mucosal immunization is highly protective in an experimental animal that supports efficient replication of SARS-CoV.
|
Authors | Ursula J Buchholz, Alexander Bukreyev, Lijuan Yang, Elaine W Lamirande, Brian R Murphy, Kanta Subbarao, Peter L Collins |
Journal | Proceedings of the National Academy of Sciences of the United States of America
(Proc Natl Acad Sci U S A)
Vol. 101
Issue 26
Pg. 9804-9
(Jun 29 2004)
ISSN: 0027-8424 [Print] United States |
PMID | 15210961
(Publication Type: Journal Article)
|
Chemical References |
- Antibodies, Viral
- DNA, Recombinant
- Membrane Glycoproteins
- Spike Glycoprotein, Coronavirus
- Viral Envelope Proteins
- Viral Matrix Proteins
- Viral Vaccines
- spike glycoprotein, SARS-CoV
|
Topics |
- Administration, Intranasal
- Animals
- Antibodies, Viral
(immunology)
- Cell Line
- Chlorocebus aethiops
- Cricetinae
- DNA, Recombinant
(genetics)
- Genetic Vectors
(genetics)
- Membrane Glycoproteins
(genetics, immunology)
- Neutralization Tests
- Parainfluenza Virus 3, Human
(genetics)
- Respiratory System
(immunology, virology)
- Severe acute respiratory syndrome-related coronavirus
(chemistry, genetics, growth & development, immunology)
- Severe Acute Respiratory Syndrome
(immunology, prevention & control, virology)
- Spike Glycoprotein, Coronavirus
- Vaccination
- Vero Cells
- Viral Envelope Proteins
(genetics, immunology)
- Viral Matrix Proteins
(genetics, immunology)
- Viral Vaccines
(administration & dosage, genetics, immunology)
- Virus Replication
(physiology)
|